Annual CFI
$32.23 M
+$68.92 M+187.84%
December 1, 2024
Summary
- As of March 13, 2025, FULC annual cash flow from investing activities is $32.23 million, with the most recent change of +$68.92 million (+187.84%) on December 1, 2024.
- During the last 3 years, FULC annual CFI has risen by +$161.90 million (+124.86%).
- FULC annual CFI is now at all-time high.
Performance
FULC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$2.26 M
-$2.09 M-48.05%
December 31, 2024
Summary
- As of March 13, 2025, FULC quarterly cash flow from investing activities is $2.26 million, with the most recent change of -$2.09 million (-48.05%) on December 31, 2024.
- Over the past year, FULC quarterly CFI has dropped by -$16.09 million (-87.69%).
- FULC quarterly CFI is now -94.07% below its all-time high of $38.13 million, reached on March 31, 2024.
Performance
FULC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$32.23 M
-$16.09 M-33.30%
December 31, 2024
Summary
- As of March 13, 2025, FULC TTM cash flow from investing activities is $32.23 million, with the most recent change of -$16.09 million (-33.30%) on December 31, 2024.
- Over the past year, FULC TTM CFI has increased by +$68.92 million (+187.84%).
- FULC TTM CFI is now -66.21% below its all-time high of $95.38 million, reached on March 31, 2024.
Performance
FULC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
FULC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +187.8% | -87.7% | +187.8% |
| 3 y3 years | +124.9% | -87.7% | +187.8% |
| 5 y5 years | +3514.2% | -87.7% | +187.8% |
FULC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +124.9% | -94.1% | +102.4% | -66.2% | +124.9% |
| 5 y | 5-year | at high | +124.9% | -94.1% | +102.1% | -66.2% | +123.8% |
| alltime | all time | at high | +124.9% | -94.1% | +102.1% | -66.2% | +123.8% |
Fulcrum Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $2.26 M(-48.0%) | $32.23 M(-33.3%) |
| Dec 2024 | $32.23 M(-187.8%) | - | - |
| Sep 2024 | - | $4.35 M(-134.8%) | $48.32 M(-23.3%) |
| Jun 2024 | - | -$12.51 M(-132.8%) | $62.99 M(-34.0%) |
| Mar 2024 | - | $38.13 M(+107.7%) | $95.38 M(-359.9%) |
| Dec 2023 | -$36.69 M(-395.6%) | $18.35 M(-3.5%) | -$36.69 M(-59.9%) |
| Sep 2023 | - | $19.02 M(-4.3%) | -$91.41 M(-18.9%) |
| Jun 2023 | - | $19.88 M(-121.2%) | -$112.71 M(+11.4%) |
| Mar 2023 | - | -$93.94 M(+158.3%) | -$101.19 M(-915.2%) |
| Dec 2022 | $12.41 M(-109.6%) | -$36.36 M(+1495.5%) | $12.41 M(-68.7%) |
| Sep 2022 | - | -$2.28 M(-107.3%) | $39.68 M(-161.4%) |
| Jun 2022 | - | $31.39 M(+59.7%) | -$64.68 M(-47.2%) |
| Mar 2022 | - | $19.66 M(-316.2%) | -$122.42 M(-5.6%) |
| Dec 2021 | -$129.67 M | -$9.09 M(-91.5%) | -$129.67 M(-4.1%) |
| Sep 2021 | - | -$106.64 M(+304.6%) | -$135.17 M(+835.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$26.35 M(-312.3%) | -$14.45 M(-223.7%) |
| Mar 2021 | - | $12.41 M(-185.0%) | $11.68 M(-120.4%) |
| Dec 2020 | -$57.14 M(+5952.8%) | -$14.60 M(-203.6%) | -$57.14 M(+34.0%) |
| Sep 2020 | - | $14.09 M(-6334.5%) | -$42.65 M(-25.1%) |
| Jun 2020 | - | -$226.00 K(-99.6%) | -$56.95 M(+0.0%) |
| Mar 2020 | - | -$56.40 M(>+9900.0%) | -$56.95 M(+5932.5%) |
| Dec 2019 | -$944.00 K(-89.5%) | -$108.00 K(-49.5%) | -$944.00 K(-78.1%) |
| Sep 2019 | - | -$214.00 K(-3.2%) | -$4.30 M(-14.2%) |
| Jun 2019 | - | -$221.00 K(-44.9%) | -$5.01 M(-41.7%) |
| Mar 2019 | - | -$401.00 K(-88.4%) | -$8.60 M(-4.3%) |
| Dec 2018 | -$8.98 M(+370.7%) | -$3.47 M(+274.3%) | -$8.98 M(+62.8%) |
| Sep 2018 | - | -$926.00 K(-75.7%) | -$5.51 M(+20.2%) |
| Jun 2018 | - | -$3.81 M(+386.1%) | -$4.59 M(+486.1%) |
| Mar 2018 | - | -$783.00 K | -$783.00 K |
| Dec 2017 | -$1.91 M | - | - |
FAQ
- What is Fulcrum Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics annual CFI year-on-year change?
- What is Fulcrum Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics quarterly CFI year-on-year change?
- What is Fulcrum Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Fulcrum Therapeutics?
- What is Fulcrum Therapeutics TTM CFI year-on-year change?
What is Fulcrum Therapeutics annual cash flow from investing activities?
The current annual CFI of FULC is $32.23 M
What is the all time high annual CFI for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high annual cash flow from investing activities is $32.23 M
What is Fulcrum Therapeutics annual CFI year-on-year change?
Over the past year, FULC annual cash flow from investing activities has changed by +$68.92 M (+187.84%)
What is Fulcrum Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of FULC is $2.26 M
What is the all time high quarterly CFI for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high quarterly cash flow from investing activities is $38.13 M
What is Fulcrum Therapeutics quarterly CFI year-on-year change?
Over the past year, FULC quarterly cash flow from investing activities has changed by -$16.09 M (-87.69%)
What is Fulcrum Therapeutics TTM cash flow from investing activities?
The current TTM CFI of FULC is $32.23 M
What is the all time high TTM CFI for Fulcrum Therapeutics?
Fulcrum Therapeutics all-time high TTM cash flow from investing activities is $95.38 M
What is Fulcrum Therapeutics TTM CFI year-on-year change?
Over the past year, FULC TTM cash flow from investing activities has changed by +$68.92 M (+187.84%)